search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


20 resulaten gevonden voor Sanofi-Aventis in trials

Het effect van behandeling van uitgezaaide prostaatkanker met cabazitaxel meten met 18F-Choline PET-CT.
- TRIAL ID
NTR6677
- ACRONYMCABAZIPET
Self-management in type 2 diabetes patients on insulin therapy triggered by app-messages
- TRIAL ID
NTR5515
- ACRONYMTRIGGER study
AVENIR project:: AGE in Vascular risk Estimation and Normalisation by Intensified Reduction in diabetes type 2.
- TRIAL ID
NTR3008
- ACRONYMAVENIR
Studying the influence of budesonide on the exposure of cabazitaxel (Jevtana®) in patients with prostate cancer.
- TRIAL ID
NTR2840
- ACRONYMN/A
Docetaxel versus Docetaxel and Lapatinib in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). An open label multicenter randomized phase II study.
A study of the Dutch Head and Neck Cancer Group (DHNCG) (NWHHT 08-02).
- TRIAL ID
NTR2507
- ACRONYMTyvTax study
Verbanden tussen therapietrouw aan glatirameer acetaat (Copaxone) en ontvangen zorg bij patienten met aanvalsgewijze multipele sclerose.
- TRIAL ID
NTR2432
- ACRONYMCAIR
Multicentric trial on the effectiveness of shortened post-infusion scalp cooling times in the prevention of docetaxel-induced hair loss.
- TRIAL ID
NTR1856
- ACRONYMSCALP3
Open label randomized phase III study of weekly docetaxel and docetaxel every 3 weeks in patients with metastatic breast cancer, resistant to prior chemotherapy
- TRIAL ID
NTR1506
- ACRONYMTAX 613
Effect of Celecoxib on reponse, progression-free and overall survival, when added to standaard first line chemotherapy in advanced ovarian cancer.
- TRIAL ID
NTR1491
- ACRONYMDocaCel
Web-based self-management of insulin titration in patients with type 2 diabetes: The Di@log Study
- TRIAL ID
NTR1316
- ACRONYMDi@log Study
Effectiveness of cultural competent diabetes education.
- TRIAL ID
NTR1076
- ACRONYMeffectiveness cultural competent diabetes education
Insulin combination therapy in type 2 diabetes.
- TRIAL ID
NTR660
- ACRONYMDIASULIN
Randomized phase II/III study of Risedronate in combination with Docetaxel versus Docetaxel alone in patients with hormone refractory prostate cancer.
- TRIAL ID
NTR469
- ACRONYMNePro
Invasive versus Conservative Treatment in Unstable coronary Syndromes.
- TRIAL ID
NTR442
- ACRONYMICTUS
Rate Control Efficacy in permanent atrial fibrillation, a comparison between lenient verus strict rate control in patients with and without heart failure.
- TRIAL ID
NTR425
- ACRONYMRACE II
Open label, comparative, randomized, multicenter, study of trastuzumab given with docetaxel versus sequential single agent therapy with trastuzumab followed by docetaxel as first-line treatment for Her2neu+++ metastatic breast cancer patients.
- TRIAL ID
NTR308
- ACRONYMHERTAX, BOOG 2002-02
Microarray Analysis in breast cancer to Tailor Adjuvant Drugs Or Regimens, a randomized phase III study.
- TRIAL ID
NTR286
- ACRONYMMATADOR, BOOG 2005-02, CKTO 2004-04
Aspirine and/or low-molecular weight heparin for women with unexplained recurrent miscarriages and/or intra-uterine fetal death.
- TRIAL ID
NTR206
- ACRONYMALIFE - Anticoagulants for Living Fetuses
A multi centre study to determine the efficacy and patient acceptability of scalp cooling in the prevention of docetaxel-induced hair loss.
- TRIAL ID
NTR90
- ACRONYMSCALP
The European First Episode Schizophrenia Trial (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens.
- TRIAL ID
NTR25
- ACRONYMEUFEST